Showing results (51-60 of 73) with videos related to

Sort By:
Pageof 8
The Lancet. Gastroenterology & Hepatology|November 18, 2017
Risk stratification after paracetamol overdose using mechanistic biomarkers: results from two prospective cohort studiesJames W Dear, Joanna I Clarke, Ben Francis, et al.
Pharmacogenetics and Genomics|April 27, 2017
TPMT, COMT and ACYP2 genetic variants in paediatric cancer patients with cisplatin-induced ototoxicitySigne Thiesen, Peng Yin, Andrea L Jorgensen, et al.
Diabetologia|January 15, 2026
Identification of a genetic risk factor for metformin-induced vitamin B12 deficiencyFaye D Baldwin, Khaled F Bedair, Andrea L Jorgensen, et al.
Clinical Pharmacology and Therapeutics|June 21, 2019
Genomewide Association Study of Statin-Induced Myopathy in Patients Recruited Using the UK Clinical Practice Research DatalinkDaniel F Carr, Ben Francis, Andrea L Jorgensen, et al.
Cell Death & Disease|December 6, 2019
Exploring the potential of BH3 mimetic therapy in squamous cell carcinoma of the head and neckRachel J Carter, Mateus Milani, Michael Butterworth, et al.
CPT: Pharmacometrics & Systems Pharmacology|December 10, 2021
Stable warfarin dose prediction in sub-Saharan African patients: A machine-learning approach and external validation of a clinical dose-initiation algorithmInnocent G Asiimwe, Marc Blockman, Karen Cohen, et al.
Frontiers in Pharmacology|October 10, 2022
A genome-wide association study of plasma concentrations of warfarin enantiomers and metabolites in sub-Saharan black-African patientsInnocent G Asiimwe, Marc Blockman, Karen Cohen, et al.
Pharmacogenetics and Genomics|September 16, 2009
Genetic and environmental factors determining clinical outcomes and cost of warfarin therapy: a prospective studyAndrea L Jorgensen, Sameh Al-Zubiedi, Jieying Eunice Zhang, et al.
Pageof 8